30
Participants
Start Date
January 31, 2014
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Panretinal photocoagulation
In cases of proliferative diabetic retinopathy (PDR), panretinal photocoagulation (PRP) is the first-line treatment. Although PRP reduces the risk of severe vision loss, it has been shown that laser energy can cause destruction to all layers of retina including the ganglion cells and the retinal nerve fiber layer (RNFL), and therefore generate visual field defects similar to that observed in glaucomatous damage. In such cases, visual field testing can be less helpful to evaluate glaucomatous damage in PDR patients treated with PRP.
Conselho Nacional de Desenvolvimento Científico e Tecnológico
OTHER_GOV
University of Sao Paulo General Hospital
OTHER